Tacrolimus Market to Show Promising Growth Opportunities By 2026

Tacrolimus Market Size, Share, Trend,
Outlook, Future Analysis And Synthesis By
Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ
rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T
lymphocytes. This suppresses T lymphocyte activation and the subsequent generation of cytotoxic
lymphocytes, thereby suppressing processes leading to organ rejection. Tacrolimus is primary
immunosuppression drug used in kidney and liver transplant patients. Organ transplanted patients often
require lifelong treatment with immunosuppressant. Major applications of this includes in cardiac
transplant rejection, liver transplant rejection, kidney transplant rejection, and lung transplant
immunosuppression treatment. Tacrolimus is available in various dosage forms such as tablets, capsules,
and injections.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2298
Tacrolimus Market Drivers
Tacrolimus is majorly used as an immunosuppressant after organ transplant procedures. Advancement in
organ transplant procedures is a major factor expected to increase the number of organ transplants,
which in turn is expected to boost global tacrolimus market growth over the forecast period. For
instance, new methods are being researched to match more donor organs with patients such as stem cell
studies, trophic factor studies, and natural models. As the need for organ transplantation increases and
the waiting list continues to grow, successful utilization and transplantation of as many available donor
organs as possible has become important. According to Organ Procurement and Transplantation Network
(OPTN) 117,000+ number of men, women, and children are on the national transplant waiting list as of
July 2017 in the U.S. and 17,155 organ transplants are done so far in 2017.
Tacrolimus Market Regional Analysis
North America tacrolimus market is expected to dominate over the forecast period. Presence of
leading manufacturers as well as high number of organ transplant procedures is expected to
support global tacrolimus market growth. Regional generic manufacturers are focusing on
providing generic version of tacrolimus formulations in developed as well emerging economies.
For instance, Strides Arcolab received the U.S. Food & Drug Administration (FDA) approval for
tacrolimus capsules to be used as immuno-suppressant in 2014. Sandoz launched Tacrolimus, a
generic version of Astellas’s PROGRAF (tacrolimus) in Japan, in 2015. Moreover, The European
Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)
recommended granting marketing authorization for tacrolimus’ generic, Tacforius in 2017. These
factors have supported the global tacrolimus market growth.
Report includes chapters which deeply display the following deliverable about industry :
• Tacrolimus Market Research Objective and Assumption
• Tacrolimus Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Tacrolimus Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Tacrolimus Market, By Regions
• Tacrolimus Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Tacrolimus Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Tacrolimus Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Tacrolimus Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Tacrolimus Market Key Players
Key players operating in the global tacrolimus market include GlaxoSmithKline Plc, Abbott Laboratories,
Novartis International AG, Mylan N.V., Astellas Pharma, Inc., Takeda Pharmaceuticals Company Ltd,
Senju Pharmaceutical Co. Ltd., Guike Pharmaceutical Co. Ltd., DR. Reddy’s Laboratories Ltd., and
Glenmark Pharmaceuticals Ltd.
Tacrolimus Market Taxonomy:
The global tacrolimus market is segmented on the basis of product type, application, end user, and
By Product Type:
Tacrolimus Capsules and Tablets
Tacrolimus Ointment
Tacrolimus Injection
By Application:
Browse Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/tacrolimusmarket-2298
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Advancement in organ transplant procedures is a major factor expected to increase the number of organ transplants, which in turn is expected to boost market growth.